A Multi-Center, Open-Label Phase 1/1b Dose Finding, Safety, and Pharmacokinetic Study of MBRC-101, an Anth-EphA5 Monomethyl Auristatin (MMAE) Antibody Drug Conjugate, in Advanced Refractory Solid Tumors.
Journal of Clinical Oncology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要